|
1
|
Almasan A and Ashkenazi A: Apo2L/TRAIL:
Apoptosis signaling, biology, and potential for cancer therapy.
Cytokine Growth Factor Rev. 14:337–348. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Micheau O, Shirley S and Dufour F: Death
receptors as targets in cancer. Br J Pharmacol. 169:1723–1744.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Peter ME and Krammer PH: The
CD95(APO-1/Fas) DISC and beyond. Cell Death Differ. 10:26–35. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kelley SK and Ashkenazi A: Targeting death
receptors in cancer with Apo2L/TRAIL. Curr Opin Pharmacol.
4:333–339. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Falschlehner C, Emmerich CH, Gerlach B and
Walczak H: TRAIL signalling: Decisions between life and death. Int
J Biochem Cell Biol. 39:1462–1475. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Griffith TS and Lynch DH: TRAIL: A
molecule with multiple receptors and control mechanisms. Curr Opin
Immunol. 10:559–563. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhu H, Zhang L, Huang X, Davis JJ, Jacob
DA, Teraishi F, Chiao P and Fang B: Overcoming acquired resistance
to TRAIL by chemotherapeutic agents and calpain inhibitor I through
distinct mechanisms. Mol Ther. 9:666–673. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Greco FA, Bonomi P, Crawford J, Kelly K,
Oh Y, Halpern W, Lo L, Gallant G and Klein J: Phase 2 study of
mapatumumab, a fully human agonistic monoclonal antibody which
targets and activates the TRAIL receptor-1, in patients with
advanced non-small cell lung cancer. Lung Cancer. 61:82–90. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Henson ES, Johnston JB and Gibson SB: The
role of TRAIL death receptors in the treatment of hematological
malignancies. Leuk Lymphoma. 49:27–35. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Humphreys RC and Halpern W: Trail
receptors: Targets for cancer therapy. Adv Exp Med Biol.
615:127–158. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ndozangue-Touriguine O, Sebbagh M, Mérino
D, Micheau O, Bertoglio J and Bréard J: A mitochondrial block and
expression of XIAP lead to resistance to TRAIL-induced apoptosis
during progression to metastasis of a colon carcinoma. Oncogene.
27:6012–6022. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Thorburn A, Behbakht K and Ford H: TRAIL
receptor-targeted therapeutics: Resistance mechanisms and
strategies to avoid them. Drug Resist Updat. 11:17–24. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mahalingam D, Szegezdi E, Keane M, de Jong
S and Samali A: TRAIL receptor signalling and modulation: Are we on
the right TRAIL? Cancer Treat Rev. 35:280–288. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kaufmann T, Strasser A and Jost PJ: Fas
death receptor signalling: Roles of Bid and XIAP. Cell Death
Differ. 19:42–50. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Srivastava RK: TRAIL/Apo-2L: Mechanisms
and clinical applications in cancer. Neoplasia. 3:535–546. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Morizot A, Mérino D, Lalaoui N, Jacquemin
G, Granci V, Iessi E, Lanneau D, Bouyer F, Solary E, Chauffert B,
et al: Chemotherapy overcomes TRAIL-R4-mediated TRAIL resistance at
the DISC level. Cell Death Differ. 18:700–711. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jacquemin G, Granci V, Gallouet AS,
Lalaoui N, Morlé A, Iessi E, Morizot A, Garrido C, Guillaudeux T
and Micheau O: Quercetin-mediated Mcl-1 and survivin downregulation
restores TRAIL-induced apoptosis in non-Hodgkin's lymphoma B cells.
Haematologica. 97:38–46. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Morlé A, Garrido C and Micheau O:
Hyperthermia restores apoptosis induced by death receptors through
aggregation-induced c-FLIP cytosolic depletion. Cell Death Dis.
6:e16332015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Blunt JW, Copp BR, Munro MH, Northcote PT
and Prinsep MR: Marine natural products. Nat Prod Rep. 23:26–78.
2006. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mayer AM, Rodríguez AD, Berlinck RG and
Hamann MT: Marine pharmacology in 2003-4: Marine compounds with
anthelmintic antibacterial, anticoagulant, antifungal,
anti-inflammatory, antimalarial, antiplatelet, antiprotozoal,
antituberculosis, and antiviral activities; affecting the
cardiovascular, immune and nervous systems, and other miscellaneous
mechanisms of action. Comp Biochem Physiol C Toxicol Pharmacol.
145:553–581. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Williams PG: Panning for chemical gold:
Marine bacteria as a source of new therapeutics. Trends Biotechnol.
27:45–52. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Blunt JW, Copp BR, Hu WP, Munro MH,
Northcote PT and Prinsep MR: Marine natural products. Nat Prod Rep.
26:170–244. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fenical W, Sethna KM and Lloyd GK: Marine
microorganisms as a developing resource for drug discovery. Pharm
News. 9:489–494. 2002.
|
|
24
|
Abdelfattah MS: A new bioactive
aminophenoxazinone alkaloid from a marine-derived actinomycete. Nat
Prod Res. 27:2126–2131. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Abdelfattah MS, Ishikawa N, Karmakar UK,
Yamaku K and Ishibashi M: New phenazine analogues from Streptomyces
sp. IFM 11694 with TRAIL resistance-overcoming activities. J
Antibiot (Tokyo). 69:446–450. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Abdelfattah MS, Toume K and Ishibashi M:
Yoropyrazone, a new naphthopyridazone alkaloid isolated from
Streptomyces sp. IFM 11307 and evaluation of its TRAIL
resistance-overcoming activity. J Antibiot (Tokyo). 65:245–248.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Abdelfattah MS, Ishikawa N, Karmakar UK
and Ishibashi M: Sulfotanone, a new alkyl sulfonic acid derivative
from Streptomyces sp. IFM 11694 with TRAIL resistance-overcoming
activity. J Nat Med. 70:266–270. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Abdelfattah MS, Kazufumi T and Ishibashi
M: New pyranonaphthoquinones and a phenazine alkaloid isolated from
Streptomyces sp. IFM 11307 with TRAIL resistance-overcoming
activity. J Antibiot (Tokyo). 64:729–734. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Abdelfattah MS, Kazufumi T and Ishibashi
M: Izumiphenazines A-C: Isolation and structure elucidation of
phenazine derivatives from Streptomyces sp. IFM 11204. J Nat Prod.
73:1999–2002. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Elmallah MIY and Micheau O: Marine drugs
regulating apoptosis induced by tumor necrosis factor-related
apoptosis-inducing ligand (TRAIL). Mar Drugs. 13:6884–6909. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hayakawa M and Nonomura H: Humic
acid-vitamin agar, a new medium for the selective isolation of soil
actinomycetes. J Ferment Technol. 65:501–509. 1987. View Article : Google Scholar
|
|
32
|
Kuester E and Williams ST: Selection of
media for the isolation of streptomycetes. Nature. 202:928–929.
1964. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kieser T, Bibb MJ, Buttner MJ, Chater KF
and Hopwood DA: Practical Streptomyces Genetics. 2nd. The John
Innes Center Foundation; Norwich: 2000
|
|
34
|
Abdelfattah MS, Elmallah MIY, Hawas UW,
El-Kassema LT Abou and Eid MAG: Isolation and characterization of
marine-derived actinomycetes with cytotoxic activity from the Red
Sea coast. Asian Pac J Trop Biomed. 6:651–657. 2016. View Article : Google Scholar
|
|
35
|
LeBlanc HN and Ashkenazi A: Apo2L/TRAIL
and its death and decoy receptors. Cell Death Differ. 10:66–75.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Takahashi Y and Omura S: Isolation of new
actinomycete strains for the screening of new bioactive compounds.
J Gen Appl Microbiol. 49:141–154. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Blunt JW, Copp BR, Hu WP, Munro MH,
Northcote PT and Prinsep MR: Marine natural products. Nat Prod Rep.
24:31–86. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
38
|
Van Slambrouck S, Daniels AL, Hooten CJ,
Brock SL, Jenkins AR, Ogasawara MA, Baker JM, Adkins G, Elias EM,
Agustin VJ, et al: Effects of crude aqueous medicinal plant
extracts on growth and invasion of breast cancer cells. Oncol Rep.
17:1487–1492. 2007.PubMed/NCBI
|
|
39
|
Ferretti C, Marengo B, De Ciucis C, Nitti
M, Pronzato MA, Marinari UM, Pronzato R, Manconi R and Domenicotti
C: Effects of Agelas oroides and Petrosia ficiformis crude extracts
on human neuroblastoma cell survival. Int J Oncol. 30:161–169.
2007.PubMed/NCBI
|
|
40
|
Oliveras-Ferraros C, Fernández-Arroyo S,
Vazquez-Martin A, Lozano-Sánchez J, Cufí S, Joven J, Micol V,
Fernández-Gutiérrez A, Segura-Carretero A and Menendez JA: Crude
phenolic extracts from extra virgin olive oil circumvent de novo
breast cancer resistance to HER1/HER2-targeting drugs by inducing
GADD45-sensed cellular stress, G2/M arrest and hyperacetylation of
Histone H3. Int J Oncol. 38:1533–1547. 2011.PubMed/NCBI
|
|
41
|
Szliszka E, Zydowicz G, Janoszka B, Dobosz
C, Kowalczyk-Ziomek G and Krol W: Ethanolic extract of Brazilian
green propolis sensitizes prostate cancer cells to TRAIL-induced
apoptosis. Int J Oncol. 38:941–953. 2011.PubMed/NCBI
|
|
42
|
Abdelhamed S, Yokoyama S, Hafiyani L,
Kalauni SK, Hayakawa Y, Awale S and Saiki I: Identification of
plant extracts sensitizing breast cancer cells to TRAIL. Oncol Rep.
29:1991–1998. 2013.PubMed/NCBI
|
|
43
|
Lee YS, Lee DG, Lee JY, Kim TR, Hong SS,
Kwon SW and Kim YS: A formulated red ginseng extract upregulates
CHOP and increases TRAIL-mediated cytotoxicity in human
hepatocellular carcinoma cells. Int J Oncol. 43:591–599.
2013.PubMed/NCBI
|
|
44
|
Thorburn A: Death receptor-induced cell
killing. Cell Signal. 16:139–144. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Rao L, Perez D and White E: Lamin
proteolysis facilitates nuclear events during apoptosis. J Cell
Biol. 135:1441–1455. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sano R and Reed JC: ER stress-induced cell
death mechanisms. Biochim Biophys Acta. 1833:3460–3470. 2013.
View Article : Google Scholar : PubMed/NCBI
|
